Susquehanna International Group
BLUE

Susquehanna International Group’s bluebird bio BLUE Stock Holding History

Susquehanna International Group’s Portfolio BLUE Stock Details BLUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-56,588
Closed -$276K – 12676
2025
Q1 		$276K Buy
+56,588
New +$340K ﹤0.01% 10240
2024
Q4 		– Sell
-27,081
Closed -$237K – 12206
2024
Q3 		$281K Sell
27,081
-18,016
-40% -$300K ﹤0.01% 9740
2024
Q2 		$888K Sell
45,097
-21,568
-32% -$432K ﹤0.01% 6875
2024
Q1 		$1.71M Sell
66,665
-7,528
-10% -$193K ﹤0.01% 5703
2023
Q4 		$2.05M Buy
74,193
+44,526
+150% +$2.71M ﹤0.01% 5290
2023
Q3 		$1.8M Buy
29,667
+4,010
+16% +$282K ﹤0.01% 5331
2023
Q2 		$1.69M Sell
25,657
-38,784
-60% -$2.84M ﹤0.01% 5501
2023
Q1 		$4.1M Buy
64,441
+42,088
+188% +$4.81M ﹤0.01% 3752
2022
Q4 		$3.09M Sell
22,353
-14,944
-40% -$2.11M ﹤0.01% 3962
2022
Q3 		$4.72M Buy
37,297
+5,237
+16% +$593K ﹤0.01% 3253
2022
Q2 		$2.65M Buy
32,060
+15,334
+92% +$1.19M ﹤0.01% 4307
2022
Q1 		$1.62M Sell
16,726
-1,624
-9% -$214K ﹤0.01% 5946
2021
Q4 		$3.67M Sell
18,350
-5,738
-24% -$1.35M ﹤0.01% 4292
2021
Q3 		$5.96M Sell
24,088
-3,388
-12% -$969K ﹤0.01% 3638
2021
Q2 		$11.4M Sell
27,476
-13,766
-33% -$5.45M ﹤0.01% 2736
2021
Q1 		$16.1M Buy
41,242
+25,790
+167% +$12.7M ﹤0.01% 2157
2020
Q4 		$8.66M Buy
15,452
+4,616
+43% +$2.93M ﹤0.01% 2670
2020
Q3 		$7.57M Sell
10,836
-626
-5% -$488K ﹤0.01% 2542
2020
Q2 		$9.06M Buy
11,462
+429
+4% +$324K ﹤0.01% 2246
2020
Q1 		$6.57M Sell
11,033
-3,782
-26% -$3.69M ﹤0.01% 2226
2019
Q4 		$16.8M Buy
14,815
+221
+2% +$240K ﹤0.01% 1582
2019
Q3 		$17.4M Sell
14,594
-1,609
-10% -$2.46M 0.01% 1450
2019
Q2 		$26.7M Buy
16,203
+12,274
+312% +$21.2M 0.01% 1088
2019
Q1 		$8.01M Sell
3,929
-11,905
-75% -$21M ﹤0.01% 1952
2018
Q4 		$20.3M Buy
15,834
+1,298
+9% +$1.99M 0.01% 1056
2018
Q3 		$27.5M Sell
14,536
-11,529
-44% -$23.8M 0.01% 1074
2018
Q2 		$53M Buy
26,065
+22,695
+673% +$51.7M 0.02% 664
2018
Q1 		$7.45M Sell
3,370
-3,568
-51% -$9.08M ﹤0.01% 2085
2017
Q4 		$16M Sell
6,938
-5,795
-46% -$11.8M 0.01% 1424
2017
Q3 		$22.7M Buy
12,733
+10,168
+396% +$14.2M 0.01% 1136
2017
Q2 		$3.49M Sell
2,565
-1,380
-35% -$1.67M ﹤0.01% 2912
2017
Q1 		$4.64M Sell
3,945
-9,231
-70% -$9.42M ﹤0.01% 2447
2016
Q4 		$10.5M Buy
13,176
+2,772
+27% +$2.2M 0.01% 1517
2016
Q3 		$9.13M Buy
10,404
+371
+4% +$269K ﹤0.01% 1596
2016
Q2 		$5.63M Sell
10,033
-11,734
-54% -$6.65M ﹤0.01% 2056
2016
Q1 		$12M Buy
21,767
+18,932
+668% +$11.6M 0.01% 1388
2015
Q4 		$2.36M Sell
2,835
-12,223
-81% -$12.2M ﹤0.01% 3705
2015
Q3 		$16.7M Buy
15,058
+6,967
+86% +$12.7M 0.01% 1378
2015
Q2 		$17.6M Sell
8,091
-2,806
-26% -$5.72M 0.01% 1419
2015
Q1 		$17M Buy
10,897
+7,916
+266% +$10.4M 0.01% 1368
2014
Q4 		$3.54M Buy
2,981
+1,622
+119% +$1.08M ﹤0.01% 3447
2014
Q3 		$632K Buy
1,359
+281
+26% +$130K ﹤0.01% 6789
2014
Q2 		$539K Sell
1,078
-617
-36% -$198K ﹤0.01% 7315
2014
Q1 		$500K Buy
+1,695
New +$514K ﹤0.01% 6739

Other funds holding BLUE

Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Susquehanna International Group's BLUE Position: Q2 2025 in Review

Susquehanna International Group sold out of bluebird bio (BLUE) in Q2 2025, closing a stake of 56,588 shares — an estimated $276K sold.

Susquehanna International Group first reported a position in BLUE in Q1 2014 and held it in 44 quarters. The position peaked at $53M in Q2 2018. 3 funds tracked by Wall St. Rank hold BLUE as of Q2 2025.

  • Susquehanna International Group reported no remaining bluebird bio position as of Q2 2025 after selling out during the quarter.
  • Susquehanna International Group sold 56,588 bluebird bio shares in Q2 2025, an estimated $276K.
  • Susquehanna International Group first reported a position in bluebird bio in Q1 2014 and held it in 44 quarters.
  • Susquehanna International Group's bluebird bio position peaked at $53M in Q2 2018.
  • 3 funds tracked by Wall St. Rank held bluebird bio as of Q2 2025.

Based on Susquehanna International Group's 13F filing for Q2 2025, filed 14 Aug 2025.